1952
K. KAI et al.
and D2O (100.0 atom % D) from Acros (New Jersy,
USA). [13C6]IAA (13C6-1), an internal standard for IAA
(1), was purchased from Cambridge Isotope Laborato-
ries (Andover, MA, USA). IAA-Glc (2), OxIAA (5), and
OxIAA-Glc (6) were synthesized in a previous study.5)
The samples of [20,20-2H2]IAA-Asp (3-d2) and [20,20-
2H2]IAA-Glu (4-d2) were kindly presented by Dr. Jun
Hiratake of the Institute for Chemical Research at Kyoto
University. All other chemicals were obtained commer-
cially.
mm (GL Science, Tokyo, Japan); solvent, water:
MeCN =75:25; flow rate, 3.20 ml/min; detection, 280
nm)] gave [20,20-2H2]IAA-Glc (2-d2) as a colorless oil
1
(37 mg, 22%). H-NMR (400 MHz, CD3OD) ꢂ: 3.30–
3.65 (4H, m), 3.66 (1H, m), 3.81 (1H, d, J ¼ 12:0 Hz),
5.52 (1H, d, J ¼ 7:8 Hz, Glc, H-1), 7.01 (1H, m, IAA,
H-5), 7.09 (1H, m, IAA, H-6), 7.19 (1H, s, IAA, H-2),
7.34 (1H, d, J ¼ 8:1 Hz, IAA, H-7), 7.55 (1H, d, J ¼
7:8 Hz, IAA, H-4). 13C-NMR (100 MHz, CD3OD) ꢂ:
62.2 (Glc, C-6), 71.0 (Glc, C-2 or 4 or 5), 74.0 (Glc, C-2
or 4 or 5), 77.9 (Glc, C-3), 78.8 (Glc, C-2 or 4 or 5), 95.5
(Glc, C-1), 107.8 (IAA, C-3), 122.7 (IAA, C-7), 119.5
(IAA, C-4 or 5), 119.9 (IAA, C-4 or C-5), 122.5 (IAA,
C-6), 124.9 (IAA, C-2), 128.6 (IAA, C-3a), 137.9 (IAA,
C-7a), 172.9 (IAA, C-10). ESI-MS: m=z 338 (M ꢁ Hꢁ).
FAB-MS: m=z 362 (M þ Naþ), 339 (Mþ). HRFAB-MS:
m=z 339.1285 (Mþ, calcd. for C16H17D2NO7, 339.1287).
[20,20-2H2]-2-oxoindole-3-acetic acid (5-d2). 1-d2
(400 mg, 2.27 mmol) was dissolved in 6 ml of DMSO/
conc. HCl/AcOH (1:5:10, v/v), and the solution was
stirred for 3 h at room temperature. The mixture was
quenched in 10 ml of ice-water and then extracted with
EtOAc (3 ꢃ 15 ml). The combined EtOAc solution was
successively washed with water and brine. The organic
layer was dried over anhydrous Na2SO4 and concen-
trated in vacuo. The residue was crystallized from
Study for the deuteration of IAA (1). IAA (100 mg,
0.570 mmol) was dissolved in D2O (5 ml) containing the
specified concentration of NaOD and the mixture was
stirred under specified conditions. Every 2 days, ca.
0.5 ml of the reaction mixture was analyzed by 1H-NMR
spectroscopy.
Chemical synthesis.
[20,20-2H2]-indole-3-acetic acid (1-d2). IAA (1 g, 5.70
mmol) was dissolved in 50 ml of 1 M NaOD/D2O, and
the mixture was stirred for 4 days at 80 ꢀC. After cooling
to room temperature, the mixture was acidified with 2 M
HCl to form crystals. The crystals were washed with
water and recrystallized from EtOAc to yield a white
1
yellow substance (669 mg, 66%). H-NMR (400 MHz,
1
acetone-d6) ꢂ: 7.02 (1H, m, H-5), 7.10 (1H, m, H-6), 7.30
(1H, J ¼ 2:4 Hz, H-2), 7.39 (1H, d, J ¼ 8:1 Hz, H-7),
7.61 (1H, d, J ¼ 7:9 Hz, H-4), 10.21 (1H, br, H-1),
10.62 (1H, br, COOH). ESI-MS: m=z 178 (M þ Hþ).
1-O-([20,20-2H2]-indole-3-acetyl)-ꢀ-D-glucopyranose
(2-d2). 1-d2 (100 mg, 0.564 mmol) and 2,3,4,6-tetra-O-
benzyl-ꢁ-D-glucopyranosyl trichloroacetimidate (386
mg, 0.564 mmol) were dissolved in 3 ml of dry CH2Cl2,
and the solution was stirred overnight at 40 ꢀC. The
reaction mixture was diluted with 10 ml of CHCl3,
successively washed with a saturated aqueous NaHCO3
solution and brine, and dried over anhydrous Na2SO4.
The solvent was evaporated in vacuo, and the residue
was purified by column chromatography (hexane-EtOAc
stepwise elution) to give 1-O-([20,20-2H2]-indole-3-ace-
tyl)-2,3,4,6-tetra-O-benzyl-ꢀ-D-glucopyranose as an or-
CHCl3 to give a white pink crystal (346 mg, 79%). H-
NMR (400 MHz, DMSO-d6) ꢂ: 3.61 (1H, s, H-3), 6.81
(1H, d, J ¼ 7:7 Hz, H-8), 6.92 (1H, m, H-5), 7.16 (1H,
m, H-6), 7.22 (1H, d, J ¼ 7:3 Hz, H-7), 10.3 (1H, s, H-
1), 12.3 (1H, s, COOH). 13C-NMR (100 MHz, DMSO-
d6) ꢂ: 41.8 (C-20), 109.3 (C-4), 121.3 (C-5), 123.8 (C-7),
127.9 (C-6), 129.5 (C-3a), 143.1 (C-7a), 172.4 (C-10),
178.3 (C-2). ESI-MS: m=z 194 (M þ Hþ). HRFAB-MS:
m=z 194.0784 (M þ Hþ, calcd. for C10H8D2NO3,
194.0786).
1-O-([20,20-2H2]-2-oxoindole-3-acetyl)-ꢀ-D-glucopyra-
nose (6-d2). 5-d2 (100 mg, 0.518 mmol) and 2,3,4,6-
tetra-O-benzyl-ꢁ-D-glucopyranosyl trichloroacetimidate
(425 mg, 0.621 mmol) were dissolved in 3 ml of dry
CH2Cl2, and the solution was stirred overnight at 40 ꢀC.
The reaction mixture was diluted with 10 ml of CHCl3,
successively washed with a saturated aqueous NaHCO3
solution and brine, and then dried over anhydrous Na2-
SO4. The solvent was evaporated in vacuo, and the res-
idue was purified by column chromatography (CHCl3–
MeOH stepwise elution) to give 1-O-([20,20-2H2]2-
oxoindole-3-acetyl)-2,3,4,6-tetra-O-benzyl-ꢀ-D-glucopy-
ranose as a yellow powder (149 mg, 40%). 1H-NMR
(400 MHz, CDCl3) ꢂ: 3.54–3.81 (7H, m), 4.47–4.89 (9H,
m), 5.62 (0.5H, d, J ¼ 8:1 Hz, Glc, H-1), 5.67 (0.5H, d,
J ¼ 8:1 Hz, Glc, H-1), 6.87–7.33 (24H, m). ESI-MS:
m=z 717 (M þ Hþ).
1
ange paste (342 mg, 87%). H-NMR (400 MHz, CDCl3)
ꢂ: 3.52–3.58 (2H, m), 3.65–3.76 (4H, m), 4.34 (1H, d,
J ¼ 9:2 Hz), 4.44–4.52 (3H, m), 4.60 (1H, d, J ¼ 12:1
Hz), 4.75–4.84 (3H, m), 5.65 (1H, d, J ¼ 8:1 Hz, Glc, H-
1), 6.98 (2H, dd, J ¼ 1:9, 5.9 Hz), 7.02 (1H, d, J ¼ 2:4
Hz), 7.07–7.32 (21H, m), 7.59 (2H, d, J ¼ 7:8 Hz, IAA,
H-4), 7.99 (1H, br, IAA, H-1). ESI-MS: m=z 701 (M þ
Hþ).
1-O-([20,20-2H2]-indole-3-acetyl)-2,3,4,6-tetra-O-benz-
yl-ꢀ-D-glucopyranose (342 mg, 0.488 mmol) and 10%
(w/w) Pd-C (136 mg) were suspended in 30 ml of EtOH,
and the suspension was stirred for 6 h at room temper-
ature in an H2 atmosphere. The precipitate was removed
by filtration, and the filtrate was purified by column
chromatography (CHCl3:MeOH = 90:10). Subsequent
preparative HPLC [column, Inertsil ODS-3 10 ꢃ 250
1-O-([20,20-2H2]2-oxoindole-3-acetyl)-2,3,4,6-tetra-O-
benzyl-ꢀ-D-glucopyranose (149 mg, 0.208 mmol) and
10% (w/w) Pd-C (59.6 mg) were suspended in 10 ml
of EtOH, and the suspension was stirred for 4 h at room
temperature in an H2 atmosphere. The precipitate was